Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals

BACKGROUND: Non-serious adverse events (NSAEs) should be captured and reported because they can have a significant negative impact on patients and treatment adherence. However, the reporting of NSAEs in randomised controlled trials (RCTs) is limited. OBJECTIVE: To identify the most important NSAEs o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevance, Astrid, Tomlinson, Anneka, Ravaud, Philippe, Touboul, Suzanne, Henshall, Catherine, Tran, Viet-Thi, Cipriani, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Pharmacological Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811084/
https://www.ncbi.nlm.nih.gov/pubmed/35906006
http://dx.doi.org/10.1136/ebmental-2021-300418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811084/
https://www.ncbi.nlm.nih.gov/pubmed/35906006
http://dx.doi.org/10.1136/ebmental-2021-300418

Ejemplares similares